MTOR and gastric cancer: VCAM-1 activates the AKT–mechanistic target of rapamycin kinase pathway, which mediates the C-X-C motif chemokine ligand 1 expression and promotes human GC-derived mesenchymal stem cell recruitment, thereby increasing immunosuppression and GC progression (Zhao et al., 2024).